Skip to content

Evaluating the accuracy and effectiveness of AR pulmonary nodule marker placement navigation device in localization of small pulmonary nodules in different body positions: a prospective, multicenter, controlled clinical study

Evaluating the accuracy and effectiveness of AR pulmonary nodule marker placement navigation device in localization of small pulmonary nodules in different body positions: a prospective, multicenter, controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128766
Enrollment
Unknown
Registered
2026-07-25
Start date
2026-07-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary nodule

Interventions

Supine position group:Lung nodule localization under AR guidance
lateral position group:Lung nodule localization under AR guidance

Sponsors

Shanghai Geriatric Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years old, of either gender; 2. Confirmed as pulmonary nodules (diameter ranging from 8mm to 20mm) through chest CT scan, with a planned thoracoscopic resection; 3. The researcher deems it necessary to perform preoperative puncture localization; 4. The subjects and their guardians are able to understand the purpose of the study, sign the informed consent form, and cooperate to complete the entire trial process.

Exclusion criteria

Exclusion criteria: 1. Chest CT scan reveals significantly enlarged hilar or mediastinal lymph nodes; 2.Subjects who are not suitable for puncture localization before surgery, such as those with pleural effusion, severe damage to lung tissue, and pleural adhesions; 3.The subject has previously undergone surgery on the affected side of the chest; 4.Individuals with significant organ failure or other severe illnesses; 5.Pregnant and lactating women; 6.Participated in other clinical trials involving drugs or medical devices during the same period; 7.Other situations that the researcher deems unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Localization Accuracy;

Secondary

MeasureTime frame
Radiation exposure dose;Operation time;Incidence of complications;Adverse events/Serious adverse events;Incidence of device defects;

Countries

China

Contacts

Public ContactXu Songtao

Shanghai Geriatric Medical Center

xu.songtao@zs-hospital.sh.cn+86 21 51371990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026